newsfilter
← Latest News
Business Wire·

Iveric Bio Announces Vision Loss Reduction Data in Geographic Atrophy from Avacincaptad Pegol GATHER Trials

- Post-hoc time-to-event analysis signals up to 59% risk reduction in rate of vision loss compared to sham treatment at 12 months - - Analysis to be presented at the ARVO Annual Meeting from April 23-27, 2023 - IVERIC